| Cat. No. : |
IL25-140H |
| Description : |
Interleukin 17 (IL-17/IL-17A) is the founding member of the newly emerging family of proteins, termed the IL-17 family. This family consists of IL-17/IL17A, IL-17B, IL-17C, IL-17D, IL-17E and IL-17F that share a conserved C-terminal region but different N-terminal segments. These homologous proteins are secreted as a disulfide-linked homodimers but have significantly different biological roles. At low levels IL-17E can be found in several tissues including the brain, kidney, lung, prostate, testis, spinal cord and trachea. IL-17E has been shown to stimulate IL-8 and induces activation of NF-kB. |
| Source : |
E. Coli. |
| Amino Acid Sequence : |
MYSHWPSCCP SKGQDTSEEL LRWSTVPVPP LEPARPNRHP ESCRASEDGP LNSRAISPWR YELDRDLNRL PQDLYHARCL CPHCVSLQTG SHMDPRGNSE LLYHNQTVFY RRPCHGEKGT HKGYCLERRL YRVSLACVCV RPRVMG |
| Supplied : |
Sterile filtered solution is lyophilized from 10mM Acetic Acid with no additives. |
| Purity : |
>98% by SDS-Page and HPLC analysis. Endotoxin level is less than 0.1ng per ug (1EU/ug) of IL- 17E. |
| Reconstitution : |
Lyophilized IL-17E should be reconstituted in 10mM Acetic acid to a concentration of 0.1-1mg/ml. Allow to set at least 30 minutes, rotate or vortex mix. Centrifuge for 1-2 minutes at 1000rpm to concentrate solution in bottom of vial. This solution can be diluted into other buffered solutions or stored at 4°Cfor up to 1 week or at -20°Cfor future use. It is recommended that a carrier protein (0.1% BSA or HSA) or medium serum be added to diluted material. |
| Reactivity : |
Determined by its ability to induce IL-8 in human PBMCs using a concentration range of 10ng-100ng (will vary depending on PBMC donors). |
| Storage : |
The lyophilized powder is stable at room temperature for a few weeks but it is best stored desiccated at -20°C. Reconstituted IL-17E should be stored in working aliquots at -20°C. Avoid frequent freeze thaw cycles. |
